[email protected] +91 9789129171
ICVOO · Registering as Listener

International Conference on Viral Oncology and Oncogenesis

4 - 5 Jan 2027 Abu Dhabi, UAE Standard / Physical Participation
Listener Registration
$115
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICVOO
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICVOO conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Oncogenesis and Cancer Stem Cells +
This track will explore the mechanisms underlying oncogenesis and the role of cancer stem cells in tumor initiation and progression. Emphasis will be placed on novel therapeutic strategies targeting these cells to improve cancer treatment outcomes.
02 Malignant Transformation and Mutagenesis +
This session will focus on the processes of malignant transformation and the genetic and environmental factors that contribute to mutagenesis. Discussions will include recent findings on how these processes can be targeted for cancer prevention.
03 Advancements in Cancer Medical Research +
This track will highlight the latest advancements in cancer medical research, including innovative methodologies and technologies. Participants will discuss the implications of these advancements for clinical practice and patient outcomes.
04 Molecular Oncology and Analytics +
This session will delve into the field of molecular oncology, focusing on the application of analytics in understanding cancer biology. Topics will include biomarker discovery and the integration of big data in oncology research.
05 Cancer Health Disparities +
This track will address the critical issue of cancer health disparities, examining the socio-economic, racial, and geographic factors that influence cancer outcomes. Strategies for reducing these disparities through policy and community engagement will be discussed.
06 Innovations in Cancer Treatment and Management +
This session will explore innovative approaches to cancer treatment and management, including personalized medicine and combination therapies. The focus will be on improving patient care and enhancing treatment efficacy.
07 Clinical Management of Cancer +
This track will cover best practices in the clinical management of cancer patients, including multidisciplinary approaches to care. Emphasis will be placed on the integration of new treatment modalities into clinical practice.
08 Cancer Immunology: Current Concepts and Future Directions +
This session will focus on the latest developments in cancer immunology, including immune checkpoint inhibitors and CAR T-cell therapy. Discussions will highlight the challenges and future directions in harnessing the immune system to combat cancer.
09 Viral Oncology: Mechanisms and Therapeutic Implications +
This track will investigate the role of viruses in oncogenesis and the implications for therapeutic interventions. Participants will discuss viral mechanisms of tumorigenesis and potential strategies for viral-targeted therapies.
10 Environmental Carcinogens and Cancer Prevention +
This session will examine the impact of environmental carcinogens on cancer risk and the strategies for cancer prevention. Emphasis will be placed on public health initiatives and policy implications.
11 Chemical Therapeutics and Cancer Imaging +
This track will focus on the development of chemical therapeutics and advancements in cancer imaging technologies. Discussions will include the integration of imaging in treatment planning and monitoring therapeutic responses.